John Jui-Jen Lee

Insider Reports History

Location
Boston, MA
Signature
/s/ Jeffrey Schulz, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by John Jui-Jen Lee:

Company Role Class Num Shares Value Price $ Report Date Ownership
Decibel Therapeutics, Inc. Chief Development Officer Common Stock 0 $5.03 25 Sep 2023 Direct
Decibel Therapeutics, Inc. Chief Development Officer Stock Option (right to buy) 0 25 Sep 2023 Direct

Insider Reports Filed by John Jui-Jen Lee

Symbol Company Period Transactions Value $ Form Type Role Filing Time
/report/000089924323019497-lee-john-jui-jen-2023-09-25 Decibel Therapeutics, Inc. 25 Sep 2023 4 $0 4 Chief Development Officer 25 Sep 2023, 16:30
/report/000089924323002979-lee-john-jui-jen-2023-01-26 Decibel Therapeutics, Inc. 26 Jan 2023 2 $0 4 Chief Development Officer 30 Jan 2023, 16:26
/report/000089924322008088-lee-john-jui-jen-2022-02-25 Decibel Therapeutics, Inc. 25 Feb 2022 1 $0 4 Chief Development Officer 28 Feb 2022, 15:37